Exact Mass: 461.2059
Exact Mass Matches: 461.2059
Found 500 metabolites which its exact mass value is equals to given mass value 461.2059
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Bitolterol
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents
Orphenadrine citrate
M - Musculo-skeletal system > M03 - Muscle relaxants > M03B - Muscle relaxants, centrally acting agents > M03BC - Ethers, chemically close to antihistamines D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065686 - Cytochrome P-450 CYP2B6 Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant Orphenadrine citrate is an orally active and non-competitive NMDA receptor antagonist (crosses the blood-brain barrier) with a Ki of 6.0 μM. Orphenadrine citrate relieves stiffness, pain and discomfort due to muscle strains, sprains or other injuries. Orphenadrine citrate is also used to relieve tremors associated with parkinson's disease. Orphenadrine citrate has good neuroprotective properties, can be used in studies of neurodegenerative diseases[1][2].
Glu Ala Lys Asp
Ser Val Gln Glu
Lys Ala Glu Asp
Ala Glu Lys Asp
Thr Asn Ile Asp
Thr Gln Val Asp
Ser Gln Ile Asp
Lys Asp Ala Glu
Ala Ala Asp Trp
Ala Ala Trp Asp
Ala Asp Ala Trp
Ala Asp Glu Lys
Ala Asp Lys Glu
Ala Asp Trp Ala
Ala Glu Asp Lys
Ala Glu Gly Trp
Ala Glu Trp Gly
Ala Gly Glu Trp
Ala Gly Trp Glu
Ala Lys Asp Glu
Ala Lys Glu Asp
Ala Arg Glu Ser
Ala Arg Ser Glu
Ala Arg Thr Asp
Ala Ser Glu Arg
Ala Ser Arg Glu
Ala Thr Asp Arg
Ala Thr Arg Asp
Ala Trp Ala Asp
Ala Trp Asp Ala
Ala Trp Glu Gly
Ala Trp Gly Glu
Cys Asp Lys Pro
Cys Asp Pro Lys
Cys Lys Asp Pro
Cys Lys Pro Asp
Cys Pro Asp Lys
Cys Pro Lys Asp
Cys Pro Arg Ser
Cys Pro Ser Arg
Cys Arg Pro Ser
Cys Arg Ser Pro
Cys Ser Pro Arg
Cys Ser Arg Pro
Asp Ala Ala Trp
Asp Ala Glu Lys
Asp Ala Lys Glu
Asp Ala Arg Thr
Asp Ala Trp Ala
Asp Cys Lys Pro
Asp Cys Pro Lys
Asp Glu Ala Lys
Asp Glu Lys Ala
Asp Ile Asn Thr
Asp Ile Gln Ser
Asp Ile Ser Gln
Asp Ile Thr Asn
Asp Lys Ala Glu
Asp Lys Cys Pro
Asp Lys Glu Ala
Asp Lys Pro Cys
Asp Leu Asn Thr
Asp Leu Gln Ser
Asp Leu Ser Gln
Asp Leu Thr Asn
Asp Asn Ile Thr
Asp Asn Leu Thr
Asp Asn Thr Ile
Asp Asn Thr Leu
Asp Pro Cys Lys
Asp Pro Lys Cys
Asp Gln Ile Ser
Asp Gln Leu Ser
Asp Gln Ser Ile
Asp Gln Ser Leu
Asp Gln Thr Val
Asp Gln Val Thr
Asp Arg Ala Thr
Asp Arg Thr Ala
Asp Ser Ile Gln
Asp Ser Leu Gln
Asp Ser Gln Ile
Asp Ser Gln Leu
Asp Thr Ala Arg
Asp Thr Ile Asn
Asp Thr Leu Asn
Asp Thr Asn Ile
Asp Thr Asn Leu
Asp Thr Gln Val
Asp Thr Arg Ala
Asp Thr Val Gln
Asp Val Gln Thr
Asp Val Thr Gln
Asp Trp Ala Ala
Glu Ala Asp Lys
Glu Ala Gly Trp
Glu Ala Arg Ser
Glu Ala Ser Arg
Glu Ala Trp Gly
Glu Asp Ala Lys
Glu Asp Lys Ala
Glu Glu Gly Lys
Glu Glu Lys Gly
Glu Gly Ala Trp
Glu Gly Glu Lys
Glu Gly Lys Glu
Glu Gly Arg Thr
Glu Gly Thr Arg
Glu Gly Trp Ala
Glu Ile Asn Ser
Glu Ile Ser Asn
Glu Lys Ala Asp
Glu Lys Asp Ala
Glu Lys Glu Gly
Glu Lys Gly Glu
Glu Leu Asn Ser
Glu Leu Ser Asn
Glu Asn Ile Ser
Glu Asn Leu Ser
Glu Asn Ser Ile
Glu Asn Ser Leu
Glu Asn Thr Val
Glu Asn Val Thr
Glu Gln Ser Val
Glu Gln Val Ser
Glu Arg Ala Ser
Glu Arg Gly Thr
Glu Arg Ser Ala
Glu Arg Thr Gly
Glu Ser Ile Asn
Glu Ser Leu Asn
Glu Ser Asn Ile
Glu Ser Asn Leu
Glu Ser Gln Val
Glu Ser Arg Ala
Glu Ser Val Gln
Glu Thr Asn Val
Glu Thr Val Asn
Glu Val Asn Thr
Glu Val Gln Ser
Glu Val Ser Gln
Glu Val Thr Asn
Glu Trp Ala Gly
Glu Trp Gly Ala
Gly Ala Glu Trp
Gly Ala Trp Glu
Gly Glu Ala Trp
Gly Glu Glu Lys
Gly Glu Lys Glu
Gly Glu Trp Ala
Gly Lys Glu Glu
Gly Trp Ala Glu
Gly Trp Glu Ala
Ile Asp Asn Thr
Ile Asp Gln Ser
Ile Asp Ser Gln
Ile Asp Thr Asn
Ile Glu Asn Ser
Ile Glu Ser Asn
Ile Asn Asp Thr
Ile Asn Glu Ser
Ile Asn Ser Glu
Ile Asn Thr Asp
Ile Gln Asp Ser
Ile Gln Ser Asp
Ile Ser Asp Gln
Ile Ser Glu Asn
Ile Ser Asn Glu
Ile Ser Gln Asp
Ile Thr Asp Asn
Ile Thr Asn Asp
Lys Ala Asp Glu
Lys Cys Asp Pro
Lys Cys Pro Asp
Lys Asp Cys Pro
Lys Asp Glu Ala
Lys Asp Pro Cys
Lys Glu Ala Asp
Lys Glu Asp Ala
Lys Glu Glu Gly
Lys Glu Gly Glu
Lys Gly Glu Glu
Lys Pro Cys Asp
Lys Pro Asp Cys
Leu Asp Asn Thr
Leu Asp Gln Ser
Leu Asp Ser Gln
Leu Asp Thr Asn
Leu Glu Asn Ser
Leu Glu Ser Asn
Leu Asn Asp Thr
Leu Asn Glu Ser
Leu Asn Ser Glu
Leu Asn Thr Asp
Leu Gln Asp Ser
Leu Gln Ser Asp
Leu Ser Asp Gln
Leu Ser Glu Asn
Leu Ser Asn Glu
Leu Ser Gln Asp
Leu Thr Asp Asn
Leu Thr Asn Asp
Met Asn Pro Thr
Met Asn Thr Pro
Met Pro Asn Thr
Met Pro Gln Ser
Met Pro Ser Gln
Met Pro Thr Asn
Met Gln Pro Ser
Met Gln Ser Pro
Met Ser Pro Gln
Met Ser Gln Pro
Met Thr Asn Pro
Met Thr Pro Asn
Asn Asp Ile Thr
Asn Asp Leu Thr
Asn Asp Thr Ile
Asn Asp Thr Leu
Asn Glu Ile Ser
Asn Glu Leu Ser
Asn Glu Ser Ile
Asn Glu Ser Leu
Asn Glu Thr Val
Asn Glu Val Thr
Asn Ile Asp Thr
Asn Ile Glu Ser
Asn Ile Ser Glu
Asn Ile Thr Asp
Asn Leu Asp Thr
Asn Leu Glu Ser
Asn Leu Ser Glu
Asn Leu Thr Asp
Asn Met Pro Thr
Asn Met Thr Pro
Asn Pro Met Thr
Asn Pro Thr Met
Asn Ser Glu Ile
Asn Ser Glu Leu
Asn Ser Ile Glu
Asn Ser Leu Glu
Asn Thr Asp Ile
Asn Thr Asp Leu
Asn Thr Glu Val
Asn Thr Ile Asp
Asn Thr Leu Asp
Asn Thr Met Pro
Asn Thr Pro Met
Asn Thr Val Glu
Asn Val Glu Thr
Asn Val Thr Glu
Pro Cys Asp Lys
Pro Cys Lys Asp
Pro Cys Arg Ser
Pro Cys Ser Arg
Pro Asp Cys Lys
Pro Asp Lys Cys
Pro Lys Cys Asp
Pro Lys Asp Cys
Pro Met Asn Thr
Pro Met Gln Ser
Pro Met Ser Gln
Pro Met Thr Asn
Pro Asn Met Thr
Pro Asn Thr Met
Pro Gln Met Ser
Pro Gln Ser Met
Pro Arg Cys Ser
Pro Arg Ser Cys
Pro Ser Cys Arg
Pro Ser Met Gln
Pro Ser Gln Met
Pro Ser Arg Cys
Pro Thr Met Asn
Pro Thr Asn Met
Gln Asp Ile Ser
Gln Asp Leu Ser
Gln Asp Ser Ile
Gln Asp Ser Leu
Gln Asp Thr Val
Gln Asp Val Thr
Gln Glu Ser Val
Gln Glu Val Ser
Gln Ile Asp Ser
Gln Ile Ser Asp
Gln Leu Asp Ser
Gln Leu Ser Asp
Gln Met Pro Ser
Gln Met Ser Pro
Gln Pro Met Ser
Gln Pro Ser Met
Gln Ser Asp Ile
Gln Ser Asp Leu
Gln Ser Glu Val
Gln Ser Ile Asp
Gln Ser Leu Asp
Gln Ser Met Pro
Gln Ser Pro Met
Gln Ser Val Glu
Gln Thr Asp Val
Gln Thr Val Asp
Gln Val Asp Thr
Gln Val Glu Ser
Gln Val Ser Glu
Gln Val Thr Asp
Arg Cys Pro Ser
Arg Cys Ser Pro
Arg Pro Cys Ser
Arg Pro Ser Cys
Arg Ser Cys Pro
Arg Ser Pro Cys
Ser Cys Pro Arg
Ser Cys Arg Pro
Ser Asp Ile Gln
Ser Asp Leu Gln
Ser Asp Gln Ile
Ser Asp Gln Leu
Ser Glu Ile Asn
Ser Glu Leu Asn
Ser Glu Asn Ile
Ser Glu Asn Leu
Ser Glu Gln Val
Ser Glu Val Gln
Ser Ile Asp Gln
Ser Ile Glu Asn
Ser Ile Asn Glu
Ser Ile Gln Asp
Ser Leu Asp Gln
Ser Leu Glu Asn
Ser Leu Asn Glu
Ser Leu Gln Asp
Ser Met Pro Gln
Ser Met Gln Pro
Ser Asn Glu Ile
Ser Asn Glu Leu
Ser Asn Ile Glu
Ser Asn Leu Glu
Ser Pro Cys Arg
Ser Pro Met Gln
Ser Pro Gln Met
Ser Pro Arg Cys
Ser Gln Asp Ile
Ser Gln Asp Leu
Ser Gln Glu Val
Ser Gln Leu Asp
Ser Gln Met Pro
Ser Gln Pro Met
Ser Gln Val Glu
Ser Arg Cys Pro
Ser Arg Pro Cys
Ser Val Glu Gln
Thr Asp Ile Asn
Thr Asp Leu Asn
Thr Asp Asn Ile
Thr Asp Asn Leu
Thr Asp Gln Val
Thr Asp Val Gln
Thr Glu Asn Val
Thr Glu Val Asn
Thr Gly Glu Arg
Thr Ile Asp Asn
Thr Ile Asn Asp
Thr Leu Asp Asn
Thr Leu Asn Asp
Thr Met Asn Pro
Thr Met Pro Asn
Thr Asn Asp Ile
Thr Asn Asp Leu
Thr Asn Glu Val
Thr Asn Leu Asp
Thr Asn Met Pro
Thr Asn Pro Met
Thr Asn Val Glu
Thr Pro Met Asn
Thr Pro Asn Met
Thr Gln Asp Val
Thr Arg Ala Asp
Thr Arg Asp Ala
Thr Arg Glu Gly
Thr Arg Gly Glu
Thr Val Asp Gln
Thr Val Glu Asn
Thr Val Asn Glu
Thr Val Gln Asp
Val Asp Gln Thr
Val Asp Thr Gln
Val Glu Asn Thr
Val Glu Gln Ser
Val Glu Ser Gln
Val Glu Thr Asn
Val Asn Glu Thr
Val Asn Thr Glu
Val Gln Asp Thr
Val Gln Glu Ser
Val Gln Ser Glu
Val Gln Thr Asp
Val Ser Glu Gln
Val Ser Gln Glu
Val Thr Asp Gln
Val Thr Glu Asn
Val Thr Asn Glu
Val Thr Gln Asp
Trp Ala Ala Asp
Trp Ala Asp Ala
Trp Ala Glu Gly
Trp Ala Gly Glu
Trp Asp Ala Ala
Trp Glu Ala Gly
Trp Glu Gly Ala
Trp Gly Ala Glu
Trp Gly Glu Ala
Alogliptin benzoate
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D054795 - Incretins D007004 - Hypoglycemic Agents > D054873 - Dipeptidyl-Peptidase IV Inhibitors D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
Bms-754807
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
(S)-2-(4-(2-(3-(fluoromethyl)azetidin-1-yl)ethoxy)phenyl)-3-(3-hydroxyphenyl)-4-methyl-2H-chromen-6-ol
Dasolampanel etibutil
C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
N-[(2S,6R)-2-[(L-Ala-D-gammaGlu-)Amino]-6-amino-6-carboxyhexanoyl]-D-Ala-OH
N-tert-butyl-3-(3-tert-butyl-1-methyl-7-oxo-4H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxybenzenesulfonamide
2-[8-[[Bis(phenylmethyl)amino]methyl]-3-methyl-2,6-dioxo-7-purinyl]acetic acid ethyl ester
4-[1-[(4-methyl-2-oxo-1-benzopyran-7-yl)amino]-3-oxo-1H-isoindol-2-yl]-1-piperidinecarboxylic acid ethyl ester
1,4:3,6-Dianhydro-2-[(benzylcarbamoyl)amino]-2,5-dideoxy-5-{[4-(4-methoxyphenyl)-2-pyrimidinyl]amino}-L-iditol
(2S)-2-amino-N-(2,6-dimethylphenyl)-N-(3-pyridin-3-ylpropyl)propanamide;(2R,3R)-2,3-dihydroxybutanedioic acid
N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
(1S,9R,10R,11R)-5-(2-fluorophenyl)-10-(hydroxymethyl)-12-methyl-6-oxo-N-[(1R)-1-phenylethyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
(1S,9R,10R,11R)-12-benzyl-5-(3-fluorophenyl)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1S,9R,10R,11R)-5-(2-fluorophenyl)-10-(hydroxymethyl)-12-methyl-6-oxo-N-[(1S)-1-phenylethyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1R,9S,10S,11S)-5-(2-fluorophenyl)-10-(hydroxymethyl)-12-methyl-6-oxo-N-[(1S)-1-phenylethyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
N-[(2S,3R)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
N-[(2R,3S)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide
(1R,9S,10S,11S)-12-benzyl-5-(3-fluorophenyl)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide
N-[(2S,3S)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
N-[(2R,3R)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
N-[(2R,3R)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
N-[(2R,3S)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
N-[(2S,3R)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
N-[(2S,3S)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide
(1R,9S,10S,11S)-5-(2-fluorophenyl)-10-(hydroxymethyl)-12-methyl-6-oxo-N-[(1R)-1-phenylethyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
[(1R)-7-methoxy-1-(pyridin-4-ylmethyl)-2-(2-thiazolylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
[(1S)-7-methoxy-1-(pyridin-4-ylmethyl)-2-(2-thiazolylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
(E,5Z)-5-(chloromethylidene)-2-methyl-N-[3-methyl-1-oxo-1-[2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]butan-2-yl]dec-2-en-9-ynamide
Bitolterol
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents